Indchemie Health Specialties Pvt. Ltd.

The US Federal Trade Commission contends that a district court got it wrong in finding that Forest Laboratories, Inc. ’s side deals with generic manufacturers did not constitute unjustifiable payment

The US Federal Trade Commission contends that a district court got it wrong in finding that Forest Laboratories, Inc. ’s side deals with generic manufacturers did not constitute unjustifiable payment

Financings Biopharma financing in the final quarter of 2012 reached $4.2 billion, a 36% increase over Q3’s $3.1 billion, again boosted by a strong showing from follow-on public offerings. The fourth q

IN VITRO DIAGNOSTICS Mergers & Acquisitions Amgen Inc. deCode genetics EHF Amgen Inc. has acquired closely held human genetics firm deCODE genetics EHF for $415mm in cash. (Dec.) DeCODE was fo